GLASSHOUSE PHARMS FDA Approval ANDA 215595

ANDA 215595

GLASSHOUSE PHARMS

FDA Drug Application

Application #215595

Application Sponsors

ANDA 215595GLASSHOUSE PHARMS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL1MG/ML0ARIPIPRAZOLEARIPIPRAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2022-10-25STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

GLASSHOUSE PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215595
            [companyName] => GLASSHOUSE PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARIPIPRAZOLE","activeIngredients":"ARIPIPRAZOLE","strength":"1MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/25\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.